ALNY
Alnylam Pharmaceuticals, Inc.stockNASDAQ
At CloseNov 18, 2026 3:59:55 PM EST
149.48USD-4.486%(-7.02)2,518,169
Pre-marketNov 18, 2026 9:15:30 AM EST
156.90USD+0.256%(+0.40)
After-hoursNov 18, 2026 4:46:30 PM EST
149.58USD+0.067%(+0.10)
Loading…
Loading…
20.01B
Healthcare
Biotechnology
CEO
John Maraganore
HQ
Cambridge, MA, USA
749
Previous Close
$156.50
Beta
0.61
52-Week High
$479.79 2025-12-03
52-Week Low
$149.18 2026-11-10
SMA 50
$215.05
SMA 200
$273.68
Avg. Vol 10D
3.02M
Avg. Vol 30D
2.65M
Avg. Vol 90D
2.06M
Relative Vol
0.95
133.94M
133.51M
99.68%
5,465,979
4.10%
1.91
54%/46%
29.99%
24.06%
0.4100%
1,700,000
918
771
1,379
5.0B
2.6B
752.1M
126.64
Nov 18, 2026
Alnylam Pharmaceuticals stock hits 52-week low at 149.17 USD ·
Investing.com
Nov 17, 2026
ALNY Profile
alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.
ALNY Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 159.85 | 2026-11-11 | -6.54% | 3.235 |
| 1M | 233.29 | 2026-10-19 | -35.96% | 1.067 |
| 3M | 228.61 | 2026-08-18 | -34.65% | 1.281 |
| 6M | 286.27 | 2026-05-18 | -47.81% | 0.400 |
| 1Y | 462.30 | 2025-11-18 | -67.69% | 0.606 |
| 2Y | 232.27 | 2024-11-18 | -35.68% | — |
| 5Y | 178.98 | 2021-11-18 | -16.53% | 0.381 |
ALNY Stock Summary
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stock price today is $149.39, and today's volume is 2,518,169. ALNY is down 4.543% today. The 30 day average volume is 2.65M. ALNY market cap is $20.01B with 133.94M shares outstanding.
